Success Story: NIW Approved Without RFE! We Helped a Medical Physics Researcher Secure Success with Premium Processing Upgrade
Client’s Testimonial:
"Thank you very much for your kind message and for all your help throughout my NIW petition process. I truly appreciate your guidance and support, and I’m very happy to have received the I-140 NIW approval.”
On August 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Scholar in the Field of Medical Physics (Approval Notice).
General Field: Medical Physics
Position at the Time of Case Filing: Postdoctoral Research Scholar
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: August 13th, 2026
Processing Time: 2 months, 15 days (Premium Processing Upgrade Requested)
Case Summary:
Pioneering Research in Quantitative Imaging and Computational Dosimetry
The client is an accomplished researcher in medical physics whose work focuses on improving imaging techniques and developing methods to better understand and measure radiation dose in medical applications. In a U.S. cancer research setting, the client, also a Ph.D holder, has conducted research involving advanced medical imaging, computational modeling, radiopharmaceutical therapy, and patient-specific radiation dose assessment for oncology treatment.
Strategic Framing: How the Petition Demonstrated National Importance
Rather than relying on strong metrics alone, our petition explained how the client’s work addresses a critical need in precision cancer treatment. We demonstrated that standardized dosimetry methods can help physicians more accurately estimate radiation dose, improve treatment planning, reduce unnecessary exposure to healthy tissue, and support safer radiopharmaceutical therapy for patients with cancer.
To show that the client was well positioned to advance this work, we presented several objective indicators: the client has authored 15 peer-reviewed journal articles, including 7 first-authored articles, along with 14 peer-reviewed conference abstracts, 13 of which are first-authored, and 1 book chapter. The client has also accumulated 501 scholarly citations, reflecting meaningful recognition and impact of their research contributions.
The petition also contextualized the client’s citation record, showing that several publications ranked among the most highly cited Clinical Medicine articles for their publication years, including 3 papers in the top 1%, 4 papers in the top 10%, and 3 papers in the top 20%.
Endorsements from Field Experts
To reinforce the objective evidence, the petition included 3 letters of recommendation from experts in medical physics and radiation oncology. These letters described the significance and impact of the client’s work in the field and its relevance to ongoing advancements in medical physics and related clinical applications. One expert noted:
“In closing, [Client] has made essential contributions to quality assurance and standardization in individualized radiopharmaceutical therapy dosimetry.”
The Result
By combining rigorous bibliometric evidence with a clear explanation of the client’s contributions to precision oncology, radiation safety, and radiopharmaceutical therapy standards, the petition demonstrated that the client met the NIW standard.
USCIS approved this I-140 NIW petition without RFE after a premium processing upgrade was requested. We congratulate the client on this approval and look forward to the client’s continued contributions to medical physics, quantitative imaging, computational dosimetry, and precision cancer treatment in the United States.